Responsibility of health providers and the media in response to scientific information

European Journal of Contraception and Reproductive Health Care

Volumn 2, Issue 1, 1997, Pages 25-30

  Martinez, F ^a  

^a INSTITUT UNIVERSITARI DEXEUS   (Spain)

Author keywords

Mass media; Oral contraceptives; Scientific information

Indexed keywords

CONTRACEPTIVE AGENT;

BIOMEDICAL TECHNOLOGY ASSESSMENT; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; EPIDEMIOLOGY; FEMALE; HEALTH CARE PERSONNEL; HEALTH EDUCATION; HUMAN; INFORMATION SERVICE; MASS COMMUNICATION; MASS MEDIUM; MEDICAL ETHICS; REVIEW; VASCULAR DISEASE;

BIAS (EPIDEMIOLOGY); BREAST NEOPLASMS; CONTRACEPTIVE AGENTS; DIFFUSION OF INNOVATION; ETHICS, PROFESSIONAL; FEMALE; HEALTH EDUCATION; HEALTH PERSONNEL; HUMANS; INFORMATION SERVICES; MASS MEDIA; TECHNOLOGY ASSESSMENT, BIOMEDICAL; VASCULAR DISEASES;

EID: 0031083221     PISSN: 13625187     EISSN: None     Source Type: Journal    
DOI: 10.1080/13625189709049931     Document Type: Article

References (22)

1. Collaborative Group on Hormonal Factors in Breast Cancer. Breast cancer and hormonal contraceptives: collaborative analysis of individual data on 53 297 women with breast cancer and 100 239 women without breast cancer from 54 epidemiological studies. Lancet 1996; 347: 1713-27
2. Lidegaard O. Oral contraceptives and venous thromboembolism: an epidemiological review. Eur J Contracept Reprod Health Care 1996; 1: 13-20
3. Eur J Contracept Reprod Health Care 1996; 1: 1-63
4. Gynaecol Forum 1996; 1: 2-27
5. Departamento Médico. El cáncer de mama y los anticonceptivos orales. Bolétin Medico de IPPF 1996; 30: 4
6. Editorial: Anticoncepción hormonal Oral y Cáncer de Mama. Bolétin de la Sociedad Española de Contracepción 1996; 4: 1-2
7. Balasch J. Los modernos contraceptivos orales y riesgo de tromboembolismo venoso. Med Integral 1997; 28: 229-32
8. Potts M. Use and abuse of epidemiologic studies by the media. Adv Contracept 1991; 7 (Suppl. 3): 91-9
9. Lidegaard O, Milsom I. Oral contraceptives and thrombotic diseases: impact of new epidemiological studies. Contraception 1996; 53: 135-9
10. Lewis MA, Heinemann LAJ, MacRae KD, Bruppacher R, Spitzer WO, Transnational Research Group on Oral Contraceptives and the Health of Young Women. The increased risk of venous thromboembolism and the use of third generation progestagens: role of bias in observational research. Contraception 1996; 54: 5-13
11. Hannaford PC. Introduction. In Hannaford PC, Webb AMC, eds. Evidence-guided Prescribing of the Pill. Carnforth, UK: Parthenon Publishing, 1996; 3-6
12. Rekers H, NorpothT, Michaels A. Oral contraceptive use and venous thromboembolism: a consideration of the impact of bias and confounding factors on epidemiological studies. Eur J Contracept Reprod Health Care 1996; 1: 21-30
13. Jespersen J. Plasma resistance to activated protein C: an important link between venous thromboembolism and combined oral contraceptives - a short review. Eur J Contracept Reprod Health Care 1996; 1: 3-12
14. van Lunsen HW. Recent oral contraceptive use patterns in four European countries: evidence for selective prescribing of oral contraceptives containing third-generation progestogens. Eur J Contracept Reprod Health Care 1996; 1: 39-45
15. Westhoff CL. Oral contraceptives and venous thromboembolism: should epidemiologic associations drive clinical decision making? Contraception 1996; 54: 1-3
16. Wellings K. Help or hype: analysis of media coverage of the 1983 pill scare. Br J Fam Plann 1985; 11: 92-8
17. Furedi F, Furedi A. The International Impact of a Pill Panic in the UK. London: Birth Control Trust, 1996
18. Bromham D. Pill alerts and pill scares. Gynaecol Forum 1996; 1: 3-4
19. Walling M: Global perspectives: UK. Pill scare in profile. Gynaecol Forum 1996; 1: 18-26
20. Skjeldestad FE. Increased number of induced abortions in Norway after media coverage of adverse vascular events from the use of third generation oral contraceptives. Contraception 1997; 55: 11-14
21. Killick SR. Objective data on the impact of the pill scares. Gynaecol Forum 1996; 1: 16-17
22. Mastroianni L Jr. Non-contraceptive benefits of oral contraceptive agents. Patients should know the positive effects. Postgrad Med 1993; 93: 193-7